The inhibition of terminal oxidation by porphyrinogenic drugs.
D000818:Animals; D000983:Antipyrine / Q000494:pharmacology; D001463:Barbiturates / Q000494:pharmacology; D002219:Carbamates / Q000494:pharmacology; D002417:Cattle; D002707:Chlordiazepoxide / Q000494:pharmacology; D002724:Chlorobutanol / Q000494:pharmacology; D046508:Culture Techniques; D004579:Electron Transport / Q000187:drug effects; D006019:Glycolysis / Q000187:drug effects*; D006118:Griseofulvin / Q000494:pharmacology; D001556:Hexachlorocyclohexane / Q000494:pharmacology; D007773:Lactates / Q000096:biosynthesis; D051379:Mice; D008928:Mitochondria / Q000201:enzymology; D010088:Oxidoreductases / Q000378:metabolism*; D010600:Pharmacology; D011164:Porphyrias / Q000139:chemically induced; D011166:Porphyrins / Q000096:biosynthesis; D011725:Pyridines / Q000494:pharmacology; D013256:Steroids / Q000494:pharmacology
D001463:Barbiturates; D002219:Carbamates; D007773:Lactates; D011166:Porphyrins; D011725:Pyridines; D013256:Steroids; D006118:Griseofulvin; D001556:Hexachlorocyclohexane; D002707:Chlordiazepoxide; D010088:Oxidoreductases; D002724:Chlorobutanol; D000983:Antipyrine